InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,194.51
(
0.27%
)
US TECH 100
17,658.60
(
0.28%
)
Dow Jones
38,911.56
(
0.15%
)
Brent Oil
83.50
(
0.02%
)
Bitcoin
63,493.30
(
0.52%
)
Post# of 110177
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dexprs

Send PM Follow Ignore
Followers 45
Posts 46065
Boards Moderated 2
Alias Born 07/08/2003

dexprs

Member Level

Re: None

Wednesday, 10/18/2017 2:26:06 PM

Wednesday, October 18, 2017 2:26:06 PM

Post# of 110177
Technical View: Merck trades higher, analyst action (TheFlyOnTheWall)
THE FLY 9:26 AM ET 10/18/2017
The shares were last up over 1.3% to $64.10. At that price next resistance of significance is at the $65 area and then at the 52-week high at $66.80. Support is at the prior session closing price of $63.22. Citi upgraded the stock to Buy and upped its price target from $65 to $72. In other items of note, the FDA accepted and granted priority review for sNDA of LYNPARZA. The company said that Keytruda had more than doubled the median overall survival of study patients.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up